Orlando, FL (PRWEB) May 13, 2014 <\/p>\n
Neil Riordan, PhD will Present Umbilical Cord Mesenchymal Stem Cells (MSC) in the Treatment of Autoimmune Diseases at the 22nd Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine at the Gaylord Palms Hotel in Orlando, Florida as part of the Specialty Workshop: Stem Cells in Anti-Aging Medicine: An Update. <\/p>\n
The primary focus of this workshop is to teach medical professionals how to successfully incorporate stem cell treatments into their practices. Expert faculty will cover stem cell theory and clinical trial research for all aspects of regenerative medicine as well as stem cell treatment marketing. <\/p>\n
Dr. Riordan will discuss: Allogeneic mesenchymal stem cells mechanisms of immune modulating activities; the importance of MSC placement for clinical effect; human clinical trials demonstrating efficacy; alternative routes of MSC delivery; dose and frequency; and clinical safety of MSC. <\/p>\n
The conference will be held from May 15 17, 2014 at the Gaylord Palms Hotel in Orlando, Florida. For more information, please visit http:\/\/www.a4m.com\/anti-aging-conference-orlando-2014-may.html<\/a>. <\/p>\n About Neil Riordan PhD <\/p>\n Dr. Riordan is the founder and chairman of Medistem Panama, Inc., (MPI) a leading stem cell laboratory and research facility located in the Technology Park at the prestigious City of Knowledge in Panama City, Panama. Founded in 2007, MPI stands at the forefront of applied research on adult stem cells for several chronic diseases. MPI's stem cell laboratory is ISO 9001 certified and fully licensed by the Panamanian Ministry of Health. Dr. Riordan is the founder of Stem Cell Institute (SCI) in Panama City, Panama (est. 2007). <\/p>\n Under the umbrella of MPI subsidiary Translational Biosciences, MPI and SCI are currently conducting five IRB-approved clinical trials in Panama for multiple sclerosis, rheumatoid arthritis and osteoarthritis using human umbilical cord-derived mesenchymal stem cells, mesenchymal trophic factors and stromal vascular fraction. Additional trials for spinal cord injury, autism and cerebral palsy are slated to commence in 2014 upon IRB approval. <\/p>\n Dr. Riordan is an accomplished inventor listed on more than 25 patent families, including 11 issued patents. He is credited with a number of novel discoveries in the field of cancer research since the mid-1990s when he collaborated with his father Dr. Hugh Riordan on the effects of high-dose intravenous vitamin C on cancer cells and the tumor microenvironment. This pioneering study on vitamin Cs preferential toxicity to cancer cells notably led to a 1997 patent grant for the treatment of cancer with vitamin C. In 2010, Dr. Riordan received another patent for a new cellular cancer vaccine. <\/p>\n Dr. Riordan is also the founder of Aidan Products, which provides health care professionals with quality nutraceuticals including Stem-Kine, the only nutritional supplement that is clinically proven to increase the amount of circulating stem cells in the body for an extended period of time. Stem-Kine is currently sold in 35 countries. <\/p>\n <\/p>\n See more here: Orlando, FL (PRWEB) May 13, 2014 Neil Riordan, PhD will Present Umbilical Cord Mesenchymal Stem Cells (MSC) in the Treatment of Autoimmune Diseases at the 22nd Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine at the Gaylord Palms Hotel in Orlando, Florida as part of the Specialty Workshop: Stem Cells in Anti-Aging Medicine: An Update. The primary focus of this workshop is to teach medical professionals how to successfully incorporate stem cell treatments into their practices. Continue reading
\nNeil Riordan, PhD Presents at American Academy of Anti-Aging Medicine's 22nd Annual World Congress on Anti-Aging ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"